BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 28399889)

  • 1. Cardiac pathology in spinal muscular atrophy: a systematic review.
    Wijngaarde CA; Blank AC; Stam M; Wadman RI; van den Berg LH; van der Pol WL
    Orphanet J Rare Dis; 2017 Apr; 12(1):67. PubMed ID: 28399889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy.
    Deguise MO; De Repentigny Y; Tierney A; Beauvais A; Michaud J; Chehade L; Thabet M; Paul B; Reilly A; Gagnon S; Renaud JM; Kothary R
    EBioMedicine; 2020 May; 55():102750. PubMed ID: 32339936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation.
    Farooq F; Abadía-Molina F; MacKenzie D; Hadwen J; Shamim F; O'Reilly S; Holcik M; MacKenzie A
    Hum Mol Genet; 2013 Sep; 22(17):3415-24. PubMed ID: 23656793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothermia improves disease manifestations in SMA mice via SMN augmentation.
    Tsai LK; Chen CL; Tsai YC; Ting CH; Chien YH; Lee NC; Hwu WL
    Hum Mol Genet; 2016 Feb; 25(4):631-41. PubMed ID: 26647309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H; Shafey D; Moores JN; Kothary R
    J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Genetics Has Told Us and How It Can Inform Future Experiments for Spinal Muscular Atrophy, a Perspective.
    Blatnik AJ; McGovern VL; Burghes AHM
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy.
    Hunter G; Powis RA; Jones RA; Groen EJ; Shorrock HK; Lane FM; Zheng Y; Sherman DL; Brophy PJ; Gillingwater TH
    Hum Mol Genet; 2016 Jul; 25(13):2853-2861. PubMed ID: 27170316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.
    Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH
    PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and therapeutic targets in spinal muscular atrophy (SMA).
    Lefebvre S; Sarret C
    Arch Pediatr; 2020 Dec; 27(7S):7S3-7S8. PubMed ID: 33357595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.
    See K; Yadav P; Giegerich M; Cheong PS; Graf M; Vyas H; Lee SG; Mathavan S; Fischer U; Sendtner M; Winkler C
    Hum Mol Genet; 2014 Apr; 23(7):1754-70. PubMed ID: 24218366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch Signaling Mediates Astrocyte Abnormality in Spinal Muscular Atrophy Model Systems.
    Ohuchi K; Funato M; Yoshino Y; Ando S; Inagaki S; Sato A; Kawase C; Seki J; Saito T; Nishio H; Nakamura S; Shimazawa M; Kaneko H; Hara H
    Sci Rep; 2019 Mar; 9(1):3701. PubMed ID: 30842449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
    d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
    Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion.
    Martin JE; Nguyen TT; Grunseich C; Nofziger JH; Lee PR; Fields D; Fischbeck KH; Foran E
    J Neurosci; 2017 May; 37(21):5309-5318. PubMed ID: 28450545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy.
    Murray LM; Lee S; Bäumer D; Parson SH; Talbot K; Gillingwater TH
    Hum Mol Genet; 2010 Feb; 19(3):420-33. PubMed ID: 19884170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.
    Iyer CC; McGovern VL; Murray JD; Gombash SE; Zaworski PG; Foust KD; Janssen PM; Burghes AH
    Hum Mol Genet; 2015 Nov; 24(21):6160-73. PubMed ID: 26276812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Biochemistry of Survival Motor Neuron Protein Is Paving the Way to Novel Therapies for Spinal Muscle Atrophy.
    Lomonte P; Baklouti F; Binda O
    Biochemistry; 2020 Apr; 59(14):1391-1397. PubMed ID: 32227847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The water extract of Liuwei dihuang possesses multi-protective properties on neurons and muscle tissue against deficiency of survival motor neuron protein.
    Tseng YT; Jong YJ; Liang WF; Chang FR; Lo YC
    Phytomedicine; 2017 Oct; 34():97-105. PubMed ID: 28899515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells.
    Lin X; Li JJ; Qian WJ; Zhang QJ; Wang ZF; Lu YQ; Dong EL; He J; Wang N; Ma LX; Chen WJ
    Oncotarget; 2017 Jun; 8(26):42030-42042. PubMed ID: 28159932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.